| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 08 Mar 2024 | SALE | AdaptHealth Corp. | 47,992 | 10.92 USD | |
| 08 Mar 2024 | SALE | AdaptHealth Corp. | 4,495 | 11.03 USD | |
| 12 Mar 2024 | SALE | AdaptHealth Corp. | 114,906 | 10.70 USD | |
| 11 Mar 2024 | SALE | AdaptHealth Corp. | 88,040 | 11.13 USD | |
| 11 Mar 2024 | SALE | AdaptHealth Corp. | 94,567 | 10.92 USD | |
| 06 Jun 2022 | SALE | Mirum Pharmaceuticals, Inc. | 13,132 | 25.29 USD | |
| 06 Jun 2022 | SALE | Mirum Pharmaceuticals, Inc. | 11,868 | 25.29 USD | |
| 06 Jun 2022 | SALE | Mirum Pharmaceuticals, Inc. | 6,243 | 24.47 USD | |
| 06 Jun 2022 | SALE | Mirum Pharmaceuticals, Inc. | 155 | 25.08 USD | |
| 06 Jun 2022 | SALE | Mirum Pharmaceuticals, Inc. | 6,909 | 24.47 USD | |
| 06 Jun 2022 | SALE | Mirum Pharmaceuticals, Inc. | 171 | 25.08 USD | |
| 09 Jul 2021 | SALE | Mirum Pharmaceuticals, Inc. | 99,325 | 15.81 USD | |
| 30 Mar 2021 | CONVERSION | Edgewise Therapeutics, Inc. | 433,551 | — | |
| 30 Mar 2021 | CONVERSION | Edgewise Therapeutics, Inc. | 1,572,960 | — | |
| 30 Mar 2021 | CONVERSION | Edgewise Therapeutics, Inc. | 1,301,626 | — | |
| 30 Mar 2021 | PURCHASE | Edgewise Therapeutics, Inc. | 625,000 | 16.00 USD | |
| 30 Mar 2021 | CONVERSION | Edgewise Therapeutics, Inc. | 1,301,626 | — | deriv |
| 30 Mar 2021 | CONVERSION | Edgewise Therapeutics, Inc. | 433,551 | — | deriv |
| 30 Mar 2021 | CONVERSION | Edgewise Therapeutics, Inc. | 1,572,960 | — | deriv |
| 13 Mar 2020 | OTHER | Oncology Institute, Inc. | 2,500,000 | 10.00 USD | |
| 13 Mar 2020 | OTHER | Oncology Institute, Inc. | 2,500,000 | 10.00 USD | |
| 08 Nov 2019 | OTHER | AdaptHealth Corp. | 6,087 | 0.00 USD | |
| 08 Nov 2019 | OTHER | AdaptHealth Corp. | 652,253 | 0.00 USD | |
| 08 Nov 2019 | GRANT_AWARD | AdaptHealth Corp. | 12,400,000 | 10.00 USD | |
| 08 Nov 2019 | OTHER | AdaptHealth Corp. | 460,685 | 0.00 USD | deriv |
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| AdaptHealth Corp. | 11,528,863 | reported | 12 Mar 2024 | tx 9+12,400,000−1,469,025 |
| Oncology Institute, Inc. | 2,500,000 | reported | 13 Mar 2020 | tx 2+5,000,000 |
| Mirum Pharmaceuticals, Inc. | 1,546,433 | reported | 06 Jun 2022 | tx 7−137,803 |
| Edgewise Therapeutics, Inc. | 0 | reported | 30 Mar 2021 | tx 7+3,933,137−3,308,137 |